Skip to main content

gonadorelin

Generic: GONADORELIN HYDROCHLORIDE·Brand: Cystorelin, FACTREL, Factrel, Fertagyl, Gonabreed, LUTREPULSE KIT, Ovacyst

gonadorelin: 5 clinical trials tracked.

gonadorelin evidence translation

What we can confirm

5 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about gonadorelin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (5)

A Phase IIA Study of Sequential ("First Strike, Second Strike") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for High Risk Metastatic Castration Sensitive Prostate Cancer

NCT05189457Registry updated 2025-12-04·Phase 2
Active, not recruiting

Primary endpoint: Overall Survival

Interventionalopen32 targetStarted 2022-01Completion 2028-071 site · United StatesH. Lee Moffitt Cancer Center and Research Institute

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

NCT04037605Registry updated 2025-09-11·Early Phase 1
Active, not recruiting

Primary endpoint: Average Blood Cortisol Concentration

InterventionalRandomizedtriple5 targetStarted 2020-02Completion 2026-061 site · United StatesLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

NCT04648969Registry updated 2026-02-18·Phase 2
Completed

Primary endpoint: Average change in luteinizing hormone (LH) pulse amplitude in response to kisspeptin

Interventionalopen18 enrolledStarted 2019-05Completion 2025-081 site · United StatesStephanie B. Seminara, MD

Hormonal Mechanisms of Sleep Restriction - Axis Study

NCT03142893Registry updated 2025-09-11·Phase 1
Active, not recruiting

Primary endpoint: Average Blood Cortisol Concentration

InterventionalRandomizedtriple80 targetStarted 2017-05Completion 2026-061 site · United StatesPeter y. Liu

ATLAS: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment With Primary Radiation Therapy

NCT02531516Registry updated 2026-02-13·Phase 3
Active, not recruiting

Primary endpoint: Metastasis-Free Survival (MFS)

InterventionalRandomizeddouble1,503 targetStarted 2015-11Completion 2028-1250 sites · United StatesAragon Pharmaceuticals, Inc.